Larvol Delta - Kannon-A-Phase--Study-Assessing-the-Safety-and-Efficacy-of-PLB1004-in-EGFR-ex20ins-Mutation-Patients-With-Advanced-and-Metastatic-Nonsmall-Cell-Lung-CancerNSCLC

andamertinib (PLB1004) - Avistone Biotech

http://clinicaltrials.gov/ct2/show/NCT06015503

May 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next